PASITHEA THERAPEUTICS CORP (KTTA) Stock Cash Flow
NASDAQ:KTTA - Nasdaq - US70261F2020 - Common Stock - Currency: USD
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -15.76M | -15.51M | -11.73M | -2.17M | -41.00K | |||
| Depreciation Amortization | 649.07K | 648.50K | 5.10K | 1.40K | N/A | |||
| Change In Working Capital | -522.47K | 1.57M | 845.40K | 111.20K | 2.30K | |||
| Other non cash items | 840.02K | -140.30K | -2.81M | -1.11M | N/A | |||
| OPERATING CASH FLOW | -14.79M | -13.43M | -13.69M | -3.17M | -38.70K | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | 0.00 | -34.30K | -107.10K | -21.50K | N/A | |||
| Other Investing Activity | 54.50K | 433.30K | -2.82M | N/A | N/A | |||
| INVESTING CASH FLOW | 54.50K | 399.00K | -2.93M | -21.50K | N/A | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | 0.00 | 0.00 | N/A | N/A | |||
| Stock Issued/Repurchased | N/A | -3.73M | -3.21M | 35.37M | 282.30K | |||
| Other Financing Activity | N/A | 0.00 | 0.00 | 20.55M | N/A | |||
| FINANCING CASH FLOW | 4.54M | -3.73M | -3.21M | 55.93M | 282.30K | |||
| Exchange Rate Effect | -27.57K | -4.00K | 9.90K | -10.60K | N/A | |||
| CHANGE IN CASH | -10.22M | -16.76M | -19.81M | 52.72M | 243.70K | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -14.79M | -13.43M | -13.69M | -3.17M | -38.70K | |||
| Capital Expenditure | 0.00 | -34.30K | -107.10K | -21.50K | N/A | |||
| FREE CASH FLOW | -14.79M | -13.46M | -13.80M | -3.20M | -38.70K | |||
All data in USD